Atossa Therapeutics, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
ATOS on Nasdaq
Industry
Pharmaceutical Preparations
Location
10202 5 Th Avenue Ne, Suite 200, Seattle, WA

Insiders trading volume in the past year

Atossa Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Steven C. Quay President & CEO, Director $30K +$9.89K +49.1% May 21, 2025
H. Lawrence Remmel Director $7.18K +$7K +3889% May 15, 2025
Gregory Weaver Former EVP, CFO, & Director, Director $36.00 Nov 15, 2023
Richard Steinhart Director May 15, 2025
Stephen J. Galli Director May 15, 2025
Heather Rees Chief Financial Officer May 15, 2025
Shu-Chih Chen Director May 15, 2025
Tessa Cigler Director May 15, 2025
Kyle Guse CFO, Gen Counsel and Secretary Mar 2, 2023
Jonathan Finn Director May 15, 2025
Mark James Daniel Chief Financial Officer Oct 14, 2025

Recent Insider Transactions by Companies or Individuals for Atossa Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.